“Betaone” barley water extract suppresses ovariectomy-induced osteoporosis in vivo and RANKL-induced osteoclast differentiation in vitro
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0317894 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Yongjin Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Science & Food Management, Ewha Womans University, Seodaemun-gu, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Ovariectomy, Osteoclasts, RANK Ligand, Cell Differentiation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cooperative Research Program for Agriculture Science and Technology Development.
Abstract (Originalsprache)
Betaone is a variety of barley developed by the Korea Rural Development Administration. This study investigated the anti-osteoporosis effects of Betaone barley water extract (B1W) on ovariectomy (OVX)-induced bone loss in mice. To elucidate its mechanism, the effect of B1W on osteoclasts was assessed by measuring the protein expression of nuclear factor-activated T cells c1 (NFATc1), the expression of genes involved in osteoclast differentiation, and bone pit assays. B1W (300 mg/kg/day) significantly increased bone mineral density and bone volume fraction, but decreased trabecular separation compared to the OVX group. B1W also showed a trend towards decreasing serum C-telopeptide of collagen type 1 levels in OVX mice. Additionally, B1W reduced the expression of NFATc1 and downregulated the mRNA expression levels of various marker genes such as c-Fos, tartrate-resistant acid phosphatase (TRAP), cathepsin K (CTSK), dendritic cell-specific transmembrane protein (DC-STAMP), and osteoclast-associated Ig-like receptor (OSCAR). B1W reduced the osteoclast activity in the receptor activator of nuclear factor-κB ligand (RANKL)-treated osteoclasts by inhibiting the mitogen-activated protein kinase (MAPK) pathway. Based on the results, B1W can be considered a useful candidate for a therapeutic agent for treating conditions of bone loss and could also be used as an ingredient in health supplements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Science & Food Management, Ewha Womans University, Seodaemun-gu, Seoul, Republic of Korea.
- The DABOM Inc, Seodaemun-gu, Seoul, Republic of Korea.
- Department of Pharmacy, Sunchon National University, Suncheon-si, Jeollanam-do, Republic of Korea.
- Mokpo Marin Food-Industry Research Center, Mokpo-si, Jeollanam-do, Republic of Korea.
- Department of Food and Nutrition, Sunchon National University, Suncheon-si, Jeollanam-do, Republic of Korea.
- Crop Foundation Research Division, National Institute of Crop Science, Rural Development Administration (RDA), Wanju-si, Jeollabuk-do, Republic of Korea.
ORCID-Profile: Young-Jin Son
Förderung
- Cooperative Research Program for Agriculture Science and Technology Development
Zitieren
APA
Lee, Y., Lee, H. J., Kim, K. J., Shin, H. B., Shin, Y. A., Jin, H., Ham, J. R., Choi, S. Y., Lee, M. J., Lee, M. K., & Son, Y. J. (2025). “Betaone” barley water extract suppresses ovariectomy-induced osteoporosis in vivo and RANKL-induced osteoclast differentiation in vitro. PLOS ONE. https://doi.org/10.1371/journal.pone.0317894
Vancouver
Lee Y, Lee HJ, Kim KJ, Shin HB, Shin YA, Jin H, et al. “Betaone” barley water extract suppresses ovariectomy-induced osteoporosis in vivo and RANKL-induced osteoclast differentiation in vitro. PLOS ONE. 2025. doi:10.1371/journal.pone.0317894
BibTeX
@article{Lee2025,
author = {Lee, Yongjin and Lee, Hyun-Jin and Kim, Kwang-Jin and Shin, Han-Byeol and Shin, Yoon-A and Jin, Holim and Ham, Ju Ri and Choi, Soo-Young and Lee, Mi-Ja and Lee, Mi-Kyung and Son, Young-Jin},
title = {“Betaone” barley water extract suppresses ovariectomy-induced osteoporosis in vivo and RANKL-induced osteoclast differentiation in vitro},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0317894}
}
EUVIMED